Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 02/11/2011 15730_de.jpg

    Using Viruses to Fight Brain Tumors

    Parvoviruses can enter and kill cancer cells, but they do not cause disease in humans. Since 1992, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been studying these viruses with the aim of developing a viral therapy against dangerous brain tumors that are almost impossible to treat.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/using-viruses-to-fight-brain-tumors
  • Article - 17/10/2011 15524_de.jpg

    Papillomaviruses as cancer-causing agents and how they can be fought off

    Studies presented at the recent International Papillomavirus Conference in Berlin demonstrate that vaccination can prevent infection with the types of HPV that cause the majority of cervical cancers. New improved vaccines to prevent HPV infections as well as therapeutic vaccines that are effective in people that are already infected are currently being developed. In addition, research has shown that other cancers can also be caused by infective…

    https://www.gesundheitsindustrie-bw.de/en/article/news/papillomaviruses-as-cancer-causing-agents-and-how-they-can-be-fought-off
  • Press release - 24/08/2011

    The project ANTIGONE aims at responding to unexpected epidemic threats

    The European Commission has decided to allocate an additional 12 million euro from the EU's Research Framework Programme to reinforce Europe's capacity for tackling pathogens like the virulent Escherichia coli (E.coli) bacteria that recently infected close to 4,000 people in Europe and killed 46. The project will also try to identify possible ways of eradicating diseases and draw lessons that may help prevent threats in the future.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-project-antigone-aims-at-responding-to-unexpected-epidemic-threats
  • Article - 29/07/2011 14959_de.jpg

    Labor Dr. Merk und Kollegen - Viruses under control

    It is difficult to imagine how Ochsenhausen-based Labor Dr. Merk und Kollegen (LMK) would be able to develop, produce and test medical products for bacterial and viral contaminations without using cell cultures. The medium-sized company also produces viruses for testing and has stored more than 80 different viruses – enveloped and non-enveloped ones, animal and human pathogens – at -80˚C.

    https://www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-und-kollegen-viruses-under-control
  • Article - 25/07/2011 14841_de.jpg

    Silke Brüderlein has “green fingers” for cell cultures

    Many researchers in the biosciences work with cell cultures, but not all of them seem to understand them at a deeper level. The biologist Silke Brüderlein from the Institute of Pathology in Ulm is a specialist in cell culture and is well aware of the problems that might arise when working with cell cultures.

    https://www.gesundheitsindustrie-bw.de/en/article/news/silke-bruederlein-has-green-fingers-for-cell-cultures
  • Article - 25/07/2011 The photo shows the face of a dark-haired man with glasses.

    Christian Thoma – the control of translation enables the rapid regulation of cellular processes

    Heisenberg fellow PD Dr. Christian Thoma from the Freiburg University Medical Centre has been focusing on the regulation of translation for a number of years and has established a method that enables him to investigate translation on the molecular level. Thoma and his team have come a step closer to their goal of finding targets for the therapy of cancer and hepatitis C.

    https://www.gesundheitsindustrie-bw.de/en/article/news/christian-thoma-the-control-of-translation-enables-the-rapid-regulation-of-cellular-processes
  • Press release - 21/04/2011

    Mathematical Methods for Investigating the Hepatitis C Virus

    An international research project coordinated at Heidelberg University revolves around the development of new mathematical methods for investigating the interaction between virus and host cell as exemplified by the hepatitis C virus. The integrated “PathoSys” project assembles ten research groups of virologists, systems biologists, mathematicians, computer scientists, bioinformaticians and molecular biologists from Germany, France, Cyprus,…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mathematical-methods-for-investigating-the-hepatitis-c-virus
  • Press release - 19/03/2011 13965_de.jpg

    Detailed insights into how HI viruses leave their host cells

    Highly developed microscope technology makes it possible: researchers led by Dr. Barbara Müller of the Department of Infectiology at Heidelberg University and by Professor Don C. Lamb from the University of Munich, have for the first time ever been able to demonstrate in detail how specific proteins of human immune cells interact with HIV components to enable them to leave the infected cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/detailed-insights-into-how-hi-viruses-leave-their-host-cells
  • Article - 14/02/2011 The photo shows a model of a protein.

    A molecule that enables local virus defence

    Dr. Markus Mordstein has spent the last four years as a doctoral student at the University of Freiburg investigating the previously relatively unknown interferon lambda. He has been able to show that this molecule has similar protective functions to type I interferons and he has also found that it is far more selective in terms of the site where it exerts its effect.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-molecule-that-enables-local-virus-defence
  • Press release - 30/01/2011 13589_de.jpg

    Door opener for influenza viruses

    An international group of researchers, including scientists from the University of Tübingen, has deciphered mechanisms that enable the initiation and also the inhibition of influenza virus infections. The importin alpha-7 variant plays a crucial role in the ability of influenza A viruses to infect humans.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/door-opener-for-influenza-viruses
  • Article - 03/12/2010 The photo shows Dr. Bernd Dallmann welcoming the audience to the Science meets Business Day in the Freiburg Concert Hall.

    Review: Science meets Business Day 2010 (part I)

    Germinating seeds biosensors in the human body deaf people learning to hear again and new approaches to combat the flu virus the lectures held at the Science meets Business Day which concluded this years BioValley Science Week once again highlighted the innovations brought about through the joint efforts of research and industrial players on the Upper Rhine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-i
  • Article - 03/12/2010 13135_de.jpg

    Review: Science meets Business Day 2010 (part II)

    How can plant physiologists and seed developers work together to achieve an understanding of the processes happening in the germinating plant embryo in order to improve the seed quality of sugar beet? How can virologists find new ways to switch off the flu virus and develop a marketable vaccine in cooperation with industrial partners?

    https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-ii
  • Article - 29/11/2010 12175_de.jpg

    Against chronic liver inflammation and liver cancer

    Chronic hepatitis B and C are the major causes of liver cancer. In contrast to hepatitis B viruses, there is no hepatitis C virus vaccination available. New research carried out by Professor Bartenschlager and his colleagues from Heidelberg might give rise to new strategies for the development of vaccines and medications for the prevention and treatment of chronic hepatitis C virus infections.

    https://www.gesundheitsindustrie-bw.de/en/article/news/against-chronic-liver-inflammation-and-liver-cancer
  • Press release - 01/11/2010 12799_de.jpg

    A virus discloses its secret: how does JCV infect body cells?

    Viruses can infect cells when they detect specific attachment sites on the cells’ surface. An international group of researchers, including biochemists from Tübingen, have now discovered the molecular mechanism by which the JCV polyomavirus attaches to these receptors. The researchers deciphered the atomic structure of the virus and for the first time ever were able to prevent the virus from attaching to the host cell and causing infection.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/a-virus-discloses-its-secret-how-does-jcv-infect-body-cells
  • Press release - 08/09/2010

    Prevention and Treatment of Chronic Hepatitis C

    GENOVAC and Inserm co-develop a novel antibody-based approach for prevention and treatment of chronic hepatitis C.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/prevention-and-treatment-of-chronic-hepatitis-c
  • Dossier - 30/08/2010 12119_de.jpg

    Disease prevention through better diagnostics

    “Classical treatment approaches are not the only way to ensure good health, rehabilitation and care. In fact, it is envisaged that more effective prevention will contribute to halting the development of diseases and maintaining good health. Prevention is designed to prevent health risks and diseases, make them less likely and delay their onset.” (Declaration of the German government; Official Records of Parliament 17/845, 26th February 2010)

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/disease-prevention-through-better-diagnostics
  • Article - 30/08/2010 12172_de.jpg

    Diagnostics for the early detection of cervical cancer

    The Pap test is regarded as the most successful test for cancer ever, and has saved the lives of many women. However, the test is associated with several weaknesses. The Heidelberg-based in vitro diagnostics company mtm laboratories AG develops and commercialises highly sensitive and highly specific immunochemical tests that provide greater reliability. These tests have the potential to revolutionise the early detection of cervical cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/diagnostics-for-the-early-detection-of-cervical-cancer
  • Press release - 21/07/2010 11876_de.jpg

    One Million for Cancer Research from Manfred Lautenschläger Foundation

    When Harald zur Hausen was awarded the Nobel Prize for Medicine in 2008, Manfred Lautenschläger spontaneously offered to support the Nobel laureate’s scientific work by funding a new research team. These funds will now go to Angelika Riemer, a young scientist who plans to advance the development of a vaccine which is able to cure existing infections with carcinogenic human papillomaviruses at the German Cancer Research Center (Deutsches…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/one-million-for-cancer-research-from-manfred-lautenschlaeger-foundation
  • Dossier - 10/07/2010 Structure of a protein seen from the side and from above.<br />

    Membrane proteins

    Around thirty per cent of all cellular proteins are located in or on a biological membrane. Numerous diseases are associated with defects in these proteins. It is estimated that around 50 per cent of all drugs developed by the pharmaceutical industry in the future will target the different membranes of cells. However it is quite difficult to biochemically investigate biological membranes. These are the many reasons why many research groups and…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/membrane-proteins
  • Press release - 05/07/2010 AnDiaTec Logo

    AnDiaTec - Real cowboys have heard of Kornwestheim

    AnDiaTec GmbH & Co. KG from Kornwestheim is in high demand worldwide as a partner specialising in detection methods for bacteria and viruses. The company is a world market leader in real time PCR Kits for the detection of noroviruses. The U.S. Ministry of Agriculture even draws on the expertise of AnDiaTec in relation to virus infections in cattle. After an intensive period of research and development, the company is now expanding its sales…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/andiatec-real-cowboys-have-heard-of-kornwestheim
  • Article - 03/07/2010 The photo shows the ingredients of Paramirum, including high-quality oils and plant essences.<br />

    Erbasens: Using the power of nature

    Before setting up her own company biologist Dr. Elke Schulz amassed a wealth of knowledge in the pharmaceutical industry. Now she harnesses the power of plants to develop and sell dietary supplements and natural cosmetics. Her company Erbasens specialises in combining high-quality oils and plant essences to create products such as Paramirum that safeguards the effectiveness of the immune system and promotes the bodys defence systems.

    https://www.gesundheitsindustrie-bw.de/en/article/news/erbasens-using-the-power-of-nature
  • Press release - 14/05/2010 Computer simulation of the surface structure of a parvovirus

    Viruses against cancer: complete regression of malignant brain tumours after treatment with parvoviruses

    Studies by scientists from the German Cancer Research Centre (DKFZ) have shown that advanced glioblastomas regressed completely in rats after treatment with parvoviruses, thus significantly increasing the survival time compared with untreated animals. Parvoviruses do not cause any disease symptoms in humans and the rats treated did not show any undesired side effects, either. A clinical phase I trial on parvovirus treatment of patients with…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/viruses-against-cancer-complete-regression-of-malignant-brain-tumours-after-treatment-with-parvoviru
  • Article - 19/04/2010 The microscope image shows six spherical structures closely attached to each other.<br />

    Trying to get a virus to reveal its tricks

    The Thogoto virus is an exotic virus that presents virtually no danger to humans. A group of virologists led by Prof. Dr. Georg Kochs at the Freiburg University Medical Centre are using the virus as model system for its particular suitability in certain experiments. The group is investigating how the virus evades the antiviral defence of the infected host.

    https://www.gesundheitsindustrie-bw.de/en/article/news/trying-to-get-a-virus-to-reveal-its-tricks
  • Press release - 30/03/2010 10972_de.jpg

    Mediagnost GmbH - successfull since 25 years

    Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH in Reutlingen is one of the oldest biotechnology companies in Germany. Mediagnost offers a broad range of services including the production of antibodies proteins and viruses the analysis of samples and the customisation of raw materials. The company celebrated its 25th anniversary on 19th March 2010 with a series of events.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mediagnost-gmbh-successfull-since-25-years
  • Article - 26/03/2010 10970_de.jpg

    How do killer cells manage to survive?

    It is not easy for the body to protect itself once a virus has broken through the body’s lines of defence and caused a chronic infection. This task is made even more difficult when the intruders are viral hepatitis pathogens that attack the liver, the place where immunological tolerance is induced. Jörg Reimann (physician) and Reinhold Schirmbeck (biologist) are working on the development of T-cell-mediated therapeutic vaccination strategies to…

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-do-killer-cells-manage-to-survive

Page 6 / 8

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search